A. Topf

发表

Treatment with Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Does Not Affect Outcome in Patients with Acute Myocarditis or Myopericarditis

M. Lichtenauer, Elke Boxhammer, M. Mirna, 2022, Journal of cardiovascular development and disease.

Differences of Hemogram Parameters and Their Ratios among Patients with Takotsubo Syndrome, Acute Coronary Syndrome and Healthy Individuals

M. Lichtenauer, B. Ohnewein, M. Mirna, 2022, Life.

Pretreatment with Betablockers, a Potential Predictor of Adverse Cardiovascular Events in Takotsubo Syndrome

M. Lichtenauer, L. Motloch, Elke Boxhammer, 2022, Biomedicines.

Differential Diagnosis between Takotsubo Syndrome and Acute Coronary Syndrome—A Prospective Analysis of Novel Cardiovascular Biomarkers for a More Selective Triage

M. Lichtenauer, M. Franz, D. Kretzschmar, 2022, Journal of clinical medicine.

A Novel Clinical Score for Differential Diagnosis Between Acute Myocarditis and Acute Coronary Syndrome – The SAlzburg MYocarditis (SAMY) Score

M. Lichtenauer, L. Hehenwarter, M. Mirna, 2022, Frontiers in Medicine.

Transcatheter aortic valve implantation in a patient with suspected hereditary von Willebrand disease and severe gastrointestinal bleeding – a case report

R. Greil, U. Hoppe, M. Lichtenauer, 2019, Scottish medical journal.

Soluble ST2 as a Potential Biomarker for Risk Assessment of Pulmonary Hypertension in Patients Undergoing TAVR?

M. Lichtenauer, A. Lauten, Laura Bäz, 2022, Life.

Early antithrombotic post-discharge therapy using prophylactic DOAC or dipyridamole improves long-term survival and cardiovascular outcomes in hospitalized COVID-19 survivors

S. Matskeplishvili, V. Pavlov, L. Fiedler, 2022, Frontiers in Cardiovascular Medicine.

Tei Index Is a Useful Adjunctive Tool in the Diagnostic Workup of Patients with Acute Myocarditis

M. Lichtenauer, Fabian Vogl, M. Mirna, 2022, Journal of cardiovascular development and disease.

Biological Sex and Its Impact on Clinical Characteristics in Patients Presenting with Myocarditis

U. Hoppe, M. Lichtenauer, M. Mirna, 2021, Medical Principles and Practice.

Neutrophil-to-lymphocyte ratio and monocyte-to-lymphocyte ratio predict length of hospital stay in myocarditis

U. Hoppe, M. Lichtenauer, M. Mirna, 2021, Scientific Reports.

Management of Implantable Cardioverter-Defibrillators during Pregnancy—A Systematic Review

U. Hoppe, M. Lichtenauer, J. Kraus, 2021, Journal of clinical medicine.

Time to abandon ampicillin plus gentamicin in favour of ampicillin plus ceftriaxone in Enterococcus faecalis infective endocarditis? A meta-analysis of comparative trials

U. Hoppe, M. Lichtenauer, M. Mirna, 2021, Clinical Research in Cardiology.

Tumor necrosis factor alpha—an underestimated risk predictor in patients undergoing transcatheter aortic valve replacement (TAVR)?

C. Steinwender, C. Jung, U. Hoppe, 2021, Journal of clinical laboratory analysis.

Gender-Specific Differences in the Intensive Care Treatment of COVID-19 Patients

M. Lichtenauer, J. Kraus, L. Fiedler, 2022, Journal of personalized medicine.

Cardiac Arrhythmias in Survivors of Sudden Cardiac Death Requiring Impella Assist Device Therapy

L. Eckardt, D. Dimitroulis, B. Wernly, 2021, Journal of clinical medicine.

Clinical implications of fetuin-A.

U. Hoppe, M. Lichtenauer, B. Wernly, 2019, Advances in clinical chemistry.

Novel Biomarkers in Patients with Chronic Kidney Disease: An Analysis of Patients Enrolled in the GCKD-Study

C. Sommerer, G. Wolf, C. Jung, 2020, Journal of clinical medicine.

The Diagnostic and Therapeutic Value of Multimarker Analysis in Heart Failure. An Approach to Biomarker-Targeted Therapy

U. Hoppe, M. Lichtenauer, A. Berezin, 2020, Frontiers in Cardiovascular Medicine.

MicroRNAs in Inflammatory Heart Diseases and Sepsis-Induced Cardiac Dysfunction: A Potential Scope for the Future?

C. Jung, U. Hoppe, M. Lichtenauer, 2019, Cells.

A new player in the game: treatment with antagomiR-21a-5p significantly attenuates histological and echocardiographic effects of experimental autoimmune myocarditis.

K. Sotlar, U. Hoppe, A. Ewe, 2021, Cardiovascular research.

Analysis of Selected Cardiovascular Biomarkers in Takotsubo Cardiomyopathy and the Most Frequent Cardiomyopathies

U. Hoppe, M. Lichtenauer, R. Pistulli, 2021, Frontiers in Cardiovascular Medicine.

The differential diagnostic value of selected cardiovascular biomarkers in Takotsubo syndrome

U. Hoppe, P. Schulze, M. Lichtenauer, 2021, Clinical Research in Cardiology.

Severe Aortic Valve Stenosis and Pulmonary Hypertension: A Systematic Review of Non-Invasive Ways of Risk Stratification, Especially in Patients Undergoing Transcatheter Aortic Valve Replacement

M. Lichtenauer, A. Berezin, V. Paar, 2022, Journal of personalized medicine.

U. Hoppe, B. Strohmer, J. Kraus, 2020, Journal of Interventional Cardiac Electrophysiology.

Subcutaneous administration of levothyroxine: a novel approach to refractory hypothyroidism - A review and a case report.

U. Hoppe, M. Lichtenauer, L. Motloch, 2021, Archives of endocrinology and metabolism.

A Comparative Analysis of Novel Biomarkers in Sepsis and Cardiovascular Disease

K. Werdan, P. Schulze, A. Yilmaz, 2022, Applied Sciences.

Impact of cavotricuspid isthmus ablation for typical atrial flutter and heart failure in the elderly—results of a retrospective multi-center study

L. Eckardt, B. Strohmer, J. Kraus, 2023, Frontiers in Cardiovascular Medicine.

Effects of Angiotensin Receptor-Neprilysin Inhibitors (ARNIs) on the Glucose and Fat Metabolism Biomarkers Leptin and Fructosamine

H. Reinecke, L. Fiedler, Z. Shomanova, 2022, Journal of clinical medicine.

The Value of Fetuin-A as a Predictor to Identify Takotsubo Patients at Risk of Cardiovascular Events

U. Hoppe, M. Lichtenauer, L. Motloch, 2021, Journal of cardiovascular development and disease.

Tei Index Complements Conventional Echocardiographic Parameters in Diagnostic Workup of Suspected Takotsubo Syndrome

M. Lichtenauer, R. Rezar, Fabian Vogl, 2022, Medical Principles and Practice.